Furthermore, previous studies found that HFD also causes glucose metabolism disorder and insulin insensitivity, which are important driving factors in the occurrence of NAFLD and NASH (Lian et al., 2020), whereas FFDZ intervention markedly enhanced insulin sensitivity and glucose tolerance. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.